XBRL Proof

XBRL File

 
Document - Document and Entity Information
Document - Document and Entity Information (USD $) 9 Months Ended  
( custom:DocumentAndEntityInformationAbstract [Extension] )    
  May. 31, 2017 Jun. 29, 2017
     
     
     
Entity Registrant Name Blake Insomnia Therapeutics, Inc.  
( dei:EntityRegistrantName )    
Entity Central Index Key 0001556416  
( dei:EntityCentralIndexKey )    
Document Type 10-Q  
( dei:DocumentType )    
Document Period End Date 2017-05-31  
( dei:DocumentPeriodEndDate )    
Amendment Flag false  
( dei:AmendmentFlag )    
Current Fiscal Year End Date --08-31  
( dei:CurrentFiscalYearEndDate )    
Is Entity a Well-known Seasoned Issuer? No  
( dei:EntityWellKnownSeasonedIssuer )    
Is Entity a Voluntary Filer? No  
( dei:EntityVoluntaryFilers )    
Is Entity's Reporting Status Current? No  
( dei:EntityCurrentReportingStatus )    
Entity Filer Category Smaller Reporting Company  
( dei:EntityFilerCategory )    
Entity Public Float    
( dei:EntityPublicFloat )    
Entity Common Stock, Shares Outstanding   31,597,572
( dei:EntityCommonStockSharesOutstanding )    
Document Fiscal Period Focus Q3  
( dei:DocumentFiscalPeriodFocus )    
Document Fiscal Year Focus 2017  
( dei:DocumentFiscalYearFocus )    
(End Document - Document and Entity Information)
 
Statement - Balance Sheets
Statement - Balance Sheets (USD $)        
( us-gaap:StatementOfFinancialPositionAbstract )        
  May. 31, 2017 Aug. 31, 2016 May. 31, 2016 Aug. 31, 2015
         
         
         
ASSETS        
( us-gaap:AssetsAbstract )        
    Current Assets        
    ( us-gaap:AssetsCurrentAbstract )        
        Cash 28,800 4,783 1,212 9,509
        ( us-gaap:Cash )        
        Total Current Assets 28,800 4,783    
        ( us-gaap:AssetsCurrent )        
    TOTAL ASSETS 28,800 4,783    
    ( us-gaap:Assets )        
    Current Liabilities        
    ( us-gaap:LiabilitiesCurrentAbstract )        
        Notes payable 139,500 67,500    
        ( us-gaap:NotesPayableCurrent )        
        Accounts payable 16,440 10,797    
        ( us-gaap:AccountsPayableCurrent )        
        Due to related party 31,637 536    
        ( us-gaap:DueToRelatedPartiesCurrent )        
        Accrued interest 15,517 7,091    
        ( us-gaap:AccruedLiabilitiesCurrent )        
        Total Current Liabilities 203,094 85,924    
        ( us-gaap:LiabilitiesCurrent )        
    Total Liabilities 203,094 85,924    
    ( us-gaap:Liabilities )        
    Stockholders' (Deficit)        
    ( us-gaap:StockholdersEquityAbstract )        
        Preferred stock ($0.0001 par value; 10,000,000 authorized; no shares issued and outstanding)    
        ( us-gaap:PreferredStockValue )        
        Common stock ($0.0001 par value, 100,000,000 shares authorized; 31,597,572 shares issued and outstanding) 3,160 3,160    
        ( us-gaap:CommonStockValue )        
        Additional paid-in capital 217,775 217,775    
        ( us-gaap:AdditionalPaidInCapital )        
        Deficit accumulated during the development stage (395,229) (302,076)    
        ( us-gaap:RetainedEarningsAccumulatedDeficit )        
        Total Stockholders' (Deficit) (174,294) (81,141)    
        ( us-gaap:StockholdersEquity )        
    TOTAL LIABILITIES & STOCKHOLDERS' (DEFICIT) 28,800 4,783    
    ( us-gaap:LiabilitiesAndStockholdersEquity )        
(End Statement - Balance Sheets)
 
Statement - Balance Sheets (Parenthetical)
Statement - Balance Sheets (Parenthetical) (USD $)      
( custom:BalanceSheetUnauditedAbstract [Extension] )      
  May. 31, 2017 Aug. 31, 2016 Aug. 31, 2012
       
       
       
Stockholders' Equity (Deficit)      
( us-gaap:StockholdersEquityAbstract )      
    Preferred stock par value 0.0001 0.0001 0.0001
    ( us-gaap:PreferredStockParOrStatedValuePerShare )      
    Preferred stock shares authorized 10,000,000 10,000,000 10,000,000
    ( us-gaap:PreferredStockSharesAuthorized )      
    Preferred stock shares issued 0 0  
    ( us-gaap:PreferredStockSharesIssued )      
    Preferred stock shares outstanding 0 0  
    ( us-gaap:PreferredStockSharesOutstanding )      
    Common stock par value 0.0001 0.0001 0.0001
    ( us-gaap:CommonStockParOrStatedValuePerShare )      
    Common stock shares authorized 100,000,000 100,000,000 100,000,000
    ( us-gaap:CommonStockSharesAuthorized )      
    Common stock shares issued 31,597,572 31,597,572  
    ( us-gaap:CommonStockSharesIssued )      
    Common stock shares outstanding 31,597,572 31,597,572  
    ( us-gaap:CommonStockSharesOutstanding )      
(End Statement - Balance Sheets (Parenthetical))
 
Statement - Statements of Operations
Statement - Statements of Operations (USD $) 3 Months Ended 9 Months Ended 58 Months Ended
( us-gaap:IncomeStatementAbstract )      
  May. 31, 2017 May. 31, 2016 May. 31, 2017 May. 31, 2016 May. 31, 2017
           
           
           
Revenues          
( us-gaap:RevenuesAbstract )          
Revenues  
( us-gaap:SalesRevenueNet )          
Total Revenues          
( us-gaap:Revenues )          
Operating Costs          
( us-gaap:OperatingCostsAndExpensesAbstract )          
Administrative Expenses 38,930 4,775 82,150 24,796  
( us-gaap:OtherGeneralAndAdministrativeExpense )          
Patent Costs 2,576 2,576  
( us-gaap:LicenseCosts )          
Stock Issued for Services  
( us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims )          
Total Operating Costs 41,506 4,775 84,726 24,796  
( us-gaap:OperatingCostsAndExpenses )          
Other (Expense)          
( us-gaap:OtherExpensesAbstract )          
    Interest Expense (3,173) (1,313) (8,427) (3,521)  
    ( us-gaap:InterestExpenseOther )          
    Total Other (Expense) (3,173) (1,313) (8,427) (3,521)  
    ( us-gaap:OtherExpenses )          
Net Loss (44,679) (6,088) (93,153) (28,317) 349,331
( us-gaap:NetIncomeLoss )          
Basic loss per share          
( us-gaap:EarningsPerShareBasicAndDiluted )          
Weighted average number of common shares outstanding 31,597,572 31,597,572 31,597,572 31,597,572  
( us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted )          
(End Statement - Statements of Operations)
 
Statement - Statements of Cash Flows
Statement - Statements of Cash Flows (USD $) 3 Months Ended 9 Months Ended 58 Months Ended
( us-gaap:StatementOfCashFlowsAbstract )      
  May. 31, 2017 May. 31, 2016 May. 31, 2017 May. 31, 2016 May. 31, 2017
           
           
           
CASH FLOWS FROM OPERATING ACTIVITIES          
( us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract )          
    Net (loss) (44,679) (6,088) (93,153) (28,317) 349,331
    ( us-gaap:NetIncomeLoss )          
    Adjustments to reconcile net (loss) to net cash provided by (used in) operating activities:          
    ( us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract )          
    Changes in operating assets and liabilities:          
    ( us-gaap:IncreaseDecreaseInOperatingCapitalAbstract )          
        Increase (decrease) in accounts payable     5,643 1,499  
        ( us-gaap:IncreaseDecreaseInAccountsPayable )          
        Increase (decrease) in accounts payable related party     31,101  
        ( us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties )          
        Increase (decrease) in accrued interest     8,426 3,521  
        ( us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet )          
    Net cash (used in) operating activities     (47,983) (23,297)  
    ( us-gaap:NetCashProvidedByUsedInOperatingActivities )          
CASH FLOWS FROM FINANCING ACTIVITIES          
( us-gaap:NetCashProvidedByUsedInFinancingActivitiesAbstract )          
    Proceeds from notes paybable     72,000 15,000  
    ( us-gaap:ProceedsFromNotesPayable )          
    Net cash provided by financing activities     72,000 15,000  
    ( us-gaap:NetCashProvidedByUsedInFinancingActivities )          
Net increase (decrease) in cash     24,017 (8,297)  
( us-gaap:CashPeriodIncreaseDecrease )          
Cash at beginning of period     4,783 9,509  
( us-gaap:Cash )          
Cash at end of period 28,800 1,212 28,800 1,212 28,800
( us-gaap:Cash )          
Supplemental Disclosures of Cash Flow Information:          
( us-gaap:SupplementalCashFlowInformationAbstract )          
    Interest      
    ( us-gaap:InterestPaid )          
    Income Taxes      
    ( us-gaap:IncomeTaxesPaid )          
(End Statement - Statements of Cash Flows)
 
Disclosure - NATURE OF OPERATIONS
Disclosure - NATURE OF OPERATIONS (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 1 - NATURE OF OPERATIONS

1. NATURE OF OPERATIONS

 

Blake Insomnia Therapeutics Inc. (formerly Book it Local, Inc.)(“The Company”) was incorporated in the State of Nevada on August 11, 2012 as Book It Local, Inc. to develop its online booking system to help consumers find and hire live entertainment for weddings, corporate events, private parties, night clubs, grand openings, and other events. On September 1, 2015, the Company changed its name to Blake Insomnia Therapeutics Inc. The Company is in the development stage with no revenues and a limited operating history.

( us-gaap:NatureOfOperations )  
(End Disclosure - NATURE OF OPERATIONS)
 
Disclosure - GOING CONCERN CONSIDERATION
Disclosure - GOING CONCERN CONSIDERATION (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 2 - GOING CONCERN CONSIDERATION

2. GOING CONCERN CONSIDERATION

 

These financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred a cumulative net loss of $395,229 since its inception and requires capital for its contemplated operation and marketing activities to take place. The Company's ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of the Company's contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company's ability to continue as a going concern.

 

Future issuances of the Company's equity or debt securities will be required in order for the Company to continue to finance its operations and continue as a going concern. The Company's present revenues are insufficient to meet operating expenses. The financial statements do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

( us-gaap:SubstantialDoubtAboutGoingConcernTextBlock )  
(End Disclosure - GOING CONCERN CONSIDERATION)
 
Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s year-end is August 31.

 

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturity of three months or less to be cash equivalents.

 

Use of Estimates and Assumptions

The preparation of financial statements in conformity with generally accepted accounting principles requires that management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

 

Revenue Recognition

The Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue when it is realized or realizable and earned less estimated future doubtful accounts. The Company considers revenue realized or realizable and earned when all of the following criteria are met:

(i)persuasive evidence of an arrangement exists,
(ii)the services have been rendered and all required milestones achieved,
(iii)the sales price is fixed or determinable, and
(iv)collectability is reasonably assured.

  

Foreign Currency Translation

The financial statements are presented in United States dollars. In accordance with ASC 830, “Foreign Currency Matters”, foreign denominated monetary assets and liabilities are translated into their United States dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the year. Gains or losses resulting from foreign currency transactions are included in results of operations.

 

Stock-Based Compensation

The Company accounts for stock-based compensation using the fair value method following the guidance set forth in section 718-10 of the FASB Accounting Standards Codification for disclosure about Stock-Based Compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

 

Development Stage Company

The Company complies with Financial Accounting Standards Codification (“ASC”) 915 and Securities and Exchange Commission Act Guide 7 for its characterization of the Company as development stage enterprise.

 

Fair Value for Financial Assets and Financial Liabilities

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

 

  Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
  Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, approximate their fair values because of the short maturity of these instruments.

 

The Company does not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis, consequently, the Company did not have any fair value adjustments for assets and liabilities measured at fair value at May 31, 2017, nor gains or losses are reported in the statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the period ended May 31, 2017.

 

Income Taxes

The Company follows the accrual method of accounting for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the estimated tax consequences attributable to differences between the financial statement carrying values and their respective income tax basis (temporary differences). The effect on the deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. At May 31, 2017 a full deferred tax asset valuation allowance has been provided and no deferred tax asset has been recorded.

 

Basic and Diluted Net Income (Loss) per Share

The Company computes net income (loss) per share in accordance with ASC 260, "Earnings per Share" which requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible preferred stock, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive.

 

Recent Accounting Pronouncements

 In June 2014, the FASB issued ASU 2014-10, Development Stage Entities (Topic 915) Elimination of Certain Financial Reporting Requirements . ASU 2014-10 eliminates the distinction of a development stage entity and certain related disclosure requirements., including the elimination of inception-to-date information on the statements of operations, cash flows and shareholders’ equity. The amendments in ASU 2014-10 will be effective prospectively for annual reporting periods beginning after December 15, 2014 and interim periods within those annual periods, however early adoption is permitted for financial statements not yet issued. The Company adopted ASU 2014-10 since the quarter ended February 28, 2015, thereby no longer presenting or disclosing any information required by Topic 915.

 

The Company has reviewed all recently issued, but not yet effective, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

( us-gaap:SignificantAccountingPoliciesTextBlock )  
(End Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES)
 
Disclosure - DEVELOPMENT STAGE COMPANY
Disclosure - DEVELOPMENT STAGE COMPANY (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 4 - DEVELOPMENT STAGE COMPANY

4. DEVELOPMENT STAGE COMPANY

 

The Company is in the development stage as of May 31, 2017 and to date has had no significant operations. Recovery of the Company’s assets is dependent on future events, the outcome of which is indeterminable. In addition, successful completion of the Company’s development program and its transition, ultimately, to attaining profitable operations is dependent upon obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company’s cost structure.

( us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock )  
(End Disclosure - DEVELOPMENT STAGE COMPANY)
 
Disclosure - MATERIAL AGREEMENTS
Disclosure - MATERIAL AGREEMENTS (USD $) 9 Months Ended
( us-gaap:BankingAndThriftAbstract )  
  May. 31, 2017
   
   
   
Note 5 - MATERIAL AGREEMENTS

5. MATERIAL AGREEMENTS

 

On February 6, 2017, Blake Insomnia Therapeutics Inc. and Sajo Consulting LLC announced entry into a Letter of Intent to provide joint development and commercialization of Zleepax™, in combination with formulations to produce a series of oral drug products to aid in the treatment of insomnia. This venture looks to develop a product to treat transient insomnia through the mechanism of Blake’s proprietary formula.

( us-gaap:ScheduleOfRepurchaseAgreements )  
(End Disclosure - MATERIAL AGREEMENTS)
 
Disclosure - NOTES PAYABLE
Disclosure - NOTES PAYABLE (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 6 - NOTES PAYABLE

6. NOTES PAYABLE

 

On August 31, 2014 the Company issued a promissory note payable in the amount of $ 5,000. The note is due on May 31, 2017 and bears interest at 10% per annum.

 

On November 20, 2014 the Company issued a promissory note payable in the amount of $ 10,000. The note is due on demand and bears interest at 10% per annum

 

On January 18, 2015 the Company issued a promissory note payable in the amount of $ 10,000. The note is due on demand and bears interest at 10% per annum.

 

On June 24, 2015 the Company issued a promissory note payable in the amount of $ 12,500. The note is due on demand and bears interest at 10% per annum.

 

On December 10, 2015 the Company issued a promissory note payable in the amount of $15,000. The note is due on demand and bears interest at 10% per annum.

On July 29, 2016 the Company issued a promissory note payable in the amount of $15,000. The note is due on demand and bears interest at 10% per annum.

On September 19, 2016 the Company issued a promissory note payable in the amount of $42,000. The note is due on demand and bears interest at 10% per annum.

On March 17, 2017 the Company issued a promissory note payable in the amount of $10,000. The note is due on demand and bears interest at 10% per annum.

On April 19, 2017 the Company issued a promissory note payable in the amount of $20,000. The note is due on demand and bears interest at 10% per annum.

The interest expense for the nine months ended May 31, 2017 and May 31, 2016 is $8,427 and $3,521, respectively. 

( us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock )  
(End Disclosure - NOTES PAYABLE)
 
Disclosure - RELATED PARTY TRANSACTIONS
Disclosure - RELATED PARTY TRANSACTIONS (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 7 - RELATED PARTY TRANSACTIONS

7. RELATED PARTY TRANSACTIONS

 

The President of the Company provides management and office premises to the Company for no compensation. The effects of this immaterial to the financial statements taken as a whole.

 

A shareholder of the company paid expenses on behalf of the company in the amount of $ 3,058 during the year ended August 31, 2016. During the year ended August 31, 2016, $ 2,522 was repaid. During the period ended May 31, 2017, a shareholder of the company paid expenses of $31,101 of expenses on behalf of the company. As at May 31, 2017, there is a balance owing to the shareholder of $31,637. This balance is non-interest bearing and has no specified terms of repayment. In June 2017, the company repaid $ 20,000 of expenses to the shareholder.

( us-gaap:RelatedPartyTransactionsDisclosureTextBlock )  
(End Disclosure - RELATED PARTY TRANSACTIONS)
 
Disclosure - STOCKHOLDERS' EQUITY
Disclosure - STOCKHOLDERS' EQUITY (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 8 - STOCKHOLDERS' EQUITY

 

8. STOCKHOLDERS’ EQUITY

 

In August, 2012, the Company authorized the issue of 100,000,000 common shares of the Company at par value of $.0001and authorized the issue of 10,000,000 preferred shares at par value of $.0001.

 

During the year ended August 31, 2014, the Company issued 21,000,000 common shares in exchange for $210,000 in services rendered, valued at the closing stock price at the date of issuance.

 

On December 23, 2014, a former director of the Company agreed to tender 3,000,000 shares of the Company for cancellation in exchange for $ 10,000. In addition, the Company agreed to issue 1,500,000 shares of the Company for $ 5,000 cash and 1,500,000 for advisory services

 

At May 31, 2017, there are total of 31,597,572 common shares of the Company issued and outstanding.

( us-gaap:StockholdersEquityNoteDisclosureTextBlock )  
(End Disclosure - STOCKHOLDERS' EQUITY)
 
Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION
Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 9 - SUPPLEMENTAL CASH FLOW INFORMATION

9. SUPPLEMENTAL CASH FLOW INFORMATION

 

Supplemental disclosures of cash flow information for the periods ended May 31, 2017 and May 31, 2016 is summarized as follows:

 

Cash paid during the periods ended May 31, 2017 and May 31, 2016 for interest and income taxes is as follows:

 

     2017    2016
Interest   $—     $—  
Taxes   $—     $—  

( us-gaap:CashFlowSupplementalDisclosuresTextBlock )  
(End Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION)
 
Disclosure - SUBSEQUENT EVENTS
Disclosure - SUBSEQUENT EVENTS (USD $) 9 Months Ended
( custom:NotesToFinancialStatementsAbstract [Extension] )  
  May. 31, 2017
   
   
   
Note 10 - SUBSEQUENT EVENTS

10. SUBSEQUENT EVENTS

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to May 31, 2017 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose.

( us-gaap:SubsequentEventsTextBlock )  
(End Disclosure - SUBSEQUENT EVENTS)
 
Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) (USD $) 9 Months Ended
( custom:SummaryOfSignificantAccountingPoliciesPoliciesAbstract [Extension] )  
  May. 31, 2017
   
   
   
Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s year-end is August 31.

( us-gaap:BasisOfAccountingPolicyPolicyTextBlock )  
Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturity of three months or less to be cash equivalents.

( us-gaap:CashAndCashEquivalentsPolicyTextBlock )  
Use of Estimates and Assumptions

The preparation of financial statements in conformity with generally accepted accounting principles requires that management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

( us-gaap:UseOfEstimates )  
Revenue Recognition

The Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue when it is realized or realizable and earned less estimated future doubtful accounts. The Company considers revenue realized or realizable and earned when all of the following criteria are met:

(i)persuasive evidence of an arrangement exists,
(ii)the services have been rendered and all required milestones achieved,
(iii)the sales price is fixed or determinable, and
(iv)collectability is reasonably assured.
( us-gaap:RevenueRecognitionPolicyTextBlock )  
Foreign Currency Translation

The financial statements are presented in United States dollars. In accordance with ASC 830, “Foreign Currency Matters”, foreign denominated monetary assets and liabilities are translated into their United States dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the year. Gains or losses resulting from foreign currency transactions are included in results of operations.

( us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock )  
Stock-Based Compensation

The Company accounts for stock-based compensation using the fair value method following the guidance set forth in section 718-10 of the FASB Accounting Standards Codification for disclosure about Stock-Based Compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

( us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock )  
Development Stage Company

The Company complies with Financial Accounting Standards Codification (“ASC”) 915 and Securities and Exchange Commission Act Guide 7 for its characterization of the Company as development stage enterprise.

( us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock )  
Fair Value for Financial Assets and Financial Liabilities

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

 

  Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
  Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, approximate their fair values because of the short maturity of these instruments.

 

The Company does not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis, consequently, the Company did not have any fair value adjustments for assets and liabilities measured at fair value at May 31, 2017, nor gains or losses are reported in the statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the period ended May 31, 2017.

( us-gaap:FairValueOfFinancialInstrumentsPolicy )  
Income Taxes

The Company follows the accrual method of accounting for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the estimated tax consequences attributable to differences between the financial statement carrying values and their respective income tax basis (temporary differences). The effect on the deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. At May 31, 2017 a full deferred tax asset valuation allowance has been provided and no deferred tax asset has been recorded.

( us-gaap:IncomeTaxPolicyTextBlock )  
Basic and Diluted Net Income (Loss) per Share

The Company computes net income (loss) per share in accordance with ASC 260, "Earnings per Share" which requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible preferred stock, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive.

( us-gaap:EarningsPerSharePolicyTextBlock )  
Recent Accounting Pronouncements

In June 2014, the FASB issued ASU 2014-10, Development Stage Entities (Topic 915) Elimination of Certain Financial Reporting Requirements . ASU 2014-10 eliminates the distinction of a development stage entity and certain related disclosure requirements., including the elimination of inception-to-date information on the statements of operations, cash flows and shareholders’ equity. The amendments in ASU 2014-10 will be effective prospectively for annual reporting periods beginning after December 15, 2014 and interim periods within those annual periods, however early adoption is permitted for financial statements not yet issued. The Company adopted ASU 2014-10 since the quarter ended February 28, 2015, thereby no longer presenting or disclosing any information required by Topic 915.

 

The Company has reviewed all recently issued, but not yet effective, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

( us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock )  
(End Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies))
 
Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)
Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables) (USD $) 9 Months Ended
( custom:SupplementalCashFlowInformationTablesAbstract [Extension] )  
  May. 31, 2017
   
   
   
Cash paid during the years for interest and income taxes
     2017    2016
Interest   $—     $—  
Taxes   $—     $—  
( us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock )  
(End Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables))
 
Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details)
Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details) (USD $) 9 Months Ended
( custom:SupplementalCashFlowInformationDetailsAbstract [Extension] )  
  May. 31, 2017 May. 31, 2016
     
     
     
Interest
( us-gaap:InterestPaid )    
Taxes
( us-gaap:IncomeTaxesPaid )    
(End Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details))
 
Disclosure - NATURE OF OPERATIONS (Details Narrative)
Disclosure - NATURE OF OPERATIONS (Details Narrative) (USD $) 9 Months Ended
( custom:NatureOfOperationsDetailsNarrativeAbstract [Extension] )  
  May. 31, 2017
   
   
   
State of Incorporation State of Nevada
( dei:EntityIncorporationStateCountryName )  
Date of Incorporation 2012-08-11
( dei:EntityIncorporationDateOfIncorporation )  
Date of Name Change 2015-09-01
( custom:DateOfNameChange [Extension] )  
(End Disclosure - NATURE OF OPERATIONS (Details Narrative))
 
Disclosure - GOING CONCERN CONSIDERATION (Details Narrative)
Disclosure - GOING CONCERN CONSIDERATION (Details Narrative) (USD $) 3 Months Ended 9 Months Ended 58 Months Ended
( custom:GoingConcernConsiderationDetailsNarrativeAbstract [Extension] )      
  May. 31, 2017 May. 31, 2016 May. 31, 2017 May. 31, 2016 May. 31, 2017
           
           
           
Cumulative net loss since inception (44,679) (6,088) (93,153) (28,317) 349,331
( us-gaap:NetIncomeLoss )          
(End Disclosure - GOING CONCERN CONSIDERATION (Details Narrative))
 
Disclosure - MATERIAL AGREEMENTS (Details Narrative)
Disclosure - MATERIAL AGREEMENTS (Details Narrative) (USD $) 9 Months Ended
( us-gaap:BankingAndThriftAbstract )  
  May. 31, 2017
   
   
   
Sajo Consulting LLC agreement date 2017-02-06
( custom:SajoConsultingAgreementDate [Extension] )  
(End Disclosure - MATERIAL AGREEMENTS (Details Narrative))
 
Disclosure - NOTES PAYABLE (Details Narrative)
Disclosure - NOTES PAYABLE (Details Narrative) (USD $) 9 Months Ended                
( custom:NotePayableDetailsNarrativeAbstract [Extension] )                  
  May. 31, 2017 May. 31, 2016 Apr. 19, 2017 Mar. 17, 2017 Sep. 19, 2016 Jul. 29, 2016 Dec. 10, 2015 Jun. 24, 2015 Jan. 18, 2015 Nov. 20, 2014
                     
                     
                     
Note payable     20,000 10,000 42,000 15,000 15,000 12,500 10,000 10,000
( us-gaap:NotesPayable )                    
Promissory note payable interest rate     0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10
( custom:PromissoryNotePayableInterestRate [Extension] )                    
Interest expense 8,427 3,521                
( us-gaap:InterestExpense )                    
 
Table continued from above
 
Disclosure - NOTES PAYABLE (Details Narrative) (USD $)  
( custom:NotePayableDetailsNarrativeAbstract [Extension] )  
  Aug. 31, 2014
   
   
   
Note payable 5,000
( us-gaap:NotesPayable )  
Promissory note payable interest rate 0.10
( custom:PromissoryNotePayableInterestRate [Extension] )  
Interest expense  
( us-gaap:InterestExpense )  
(End Disclosure - NOTES PAYABLE (Details Narrative))
 
Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)
Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) (USD $) 0 Months Ended 9 Months Ended 12 Months Ended    
( custom:RelatedPartyTransactionsDetailsNarrativeAbstract [Extension] )          
  Jun. 15, 2017 May. 31, 2017 Aug. 31, 2016 May. 31, 2017 Aug. 31, 2016
           
           
           
Due Related Party       31,637 3,058
( custom:DueToRelatedParty [Extension] )          
Repayment of related party loan 20,000   2,522    
( us-gaap:RepaymentOfNotesReceivableFromRelatedParties )          
Shareholder payment on behalf of Company   31,101      
( custom:ShareholderPaymentOnBehalfOfCompany [Extension] )          
(End Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative))
 
Disclosure - STOCKHOLDERS' EQUITY (Details Narrative)
Disclosure - STOCKHOLDERS' EQUITY (Details Narrative) (USD $) 1 Month Ended 12 Months Ended      
( custom:StockholdersEquityDetailsNarrativeAbstract [Extension] )          
  Dec. 23, 2014 Dec. 23, 2014 Aug. 31, 2014 May. 31, 2017 Aug. 31, 2016 Aug. 31, 2012
( us-gaap:TitleOfIndividualAxis )            
  Former director [Member]          
( us-gaap:TitleOfIndividualWithRelationshipToEntityDomain )            
Preferred stock par value       0.0001 0.0001 0.0001
( us-gaap:PreferredStockParOrStatedValuePerShare )            
Preferred stock shares authorized       10,000,000 10,000,000 10,000,000
( us-gaap:PreferredStockSharesAuthorized )            
Common stock par value       0.0001 0.0001 0.0001
( us-gaap:CommonStockParOrStatedValuePerShare )            
Common stock shares authorized       100,000,000 100,000,000 100,000,000
( us-gaap:CommonStockSharesAuthorized )            
Common stock issued for services, Shares 1,500,000   21,000,000      
( us-gaap:StockIssuedDuringPeriodSharesIssuedForServices )            
Common stock issued for services, Amount 5,000   210,000      
( us-gaap:StockIssuedDuringPeriodValueIssuedForServices )            
Common stock surrendered for cancellation, Shares 3,000,000          
( us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited )            
Common stock surrendered for cancellation, Amount   10,000        
( us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited )            
Common stock issued for advisory services 1,500,000          
( custom:CommonStockIssuedForAdvisoryServices [Extension] )            
Common stock shares issued       31,597,572 31,597,572  
( us-gaap:CommonStockSharesIssued )            
Common stock shares outstanding       31,597,572 31,597,572  
( us-gaap:CommonStockSharesOutstanding )            
(End Disclosure - STOCKHOLDERS' EQUITY (Details Narrative))
Contexts
ID Period CIK Dimensions
From2016-09-01to2017-05-31 2016-09-01 - 2017-05-31 0001556416  
AsOf2017-06-29 2017-06-29 0001556416  
AsOf2017-05-31 2017-05-31 0001556416  
AsOf2016-08-31 2016-08-31 0001556416  
AsOf2012-08-31 2012-08-31 0001556416  
AsOf2015-08-31 2015-08-31 0001556416  
AsOf2016-05-31 2016-05-31 0001556416  
From2017-03-01to2017-05-31 2017-03-01 - 2017-05-31 0001556416  
From2016-03-01to2016-05-31 2016-03-01 - 2016-05-31 0001556416  
From2015-09-01to2016-05-31 2015-09-01 - 2016-05-31 0001556416  
From2012-08-12to2017-05-31 2012-08-12 - 2017-05-31 0001556416  
AsOf2016-09-19 2016-09-19 0001556416  
AsOf2016-07-29 2016-07-29 0001556416  
AsOf2015-12-10 2015-12-10 0001556416  
AsOf2015-06-24 2015-06-24 0001556416  
AsOf2015-01-18 2015-01-18 0001556416  
AsOf2014-11-20 2014-11-20 0001556416  
AsOf2014-08-31 2014-08-31 0001556416  
AsOf2017-03-17 2017-03-17 0001556416  
AsOf2017-04-19 2017-04-19 0001556416  
From2015-09-01to2016-08-31 2015-09-01 - 2016-08-31 0001556416  
From2017-06-01to2017-06-15 2017-06-01 - 2017-06-15 0001556416  
From2014-12-01to2014-12-23_custom_FormerDirectorMember 2014-12-01 - 2014-12-23 0001556416 us-gaap:TitleOfIndividualAxis: custom:FormerDirectorMember
From2013-09-01to2014-08-31 2013-09-01 - 2014-08-31 0001556416  
From2014-12-01to2014-12-23 2014-12-01 - 2014-12-23 0001556416  
(End Contexts)
 
Elements
Element Data Type Period Type Balance Type Custom
custom:BalanceSheetUnauditedAbstract xbrli:stringItemType  Duration    Yes
     
custom:CommonStockIssuedForAdvisoryServices xbrli:monetaryItemType  Duration  Credit  Yes
     
custom:DateOfNameChange xbrli:dateItemType  Duration    Yes
     
custom:DocumentAndEntityInformationAbstract xbrli:stringItemType  Duration    Yes
     
custom:DueToRelatedParty xbrli:monetaryItemType  Instant    Yes
     
custom:FormerDirectorMember nonnum:domainItemType  Duration    Yes
     
custom:GoingConcernConsiderationDetailsNarrativeAbstract xbrli:stringItemType  Duration    Yes
     
custom:NatureOfOperationsDetailsNarrativeAbstract xbrli:stringItemType  Duration    Yes
     
custom:NotePayableDetailsNarrativeAbstract xbrli:stringItemType  Duration    Yes
     
custom:NotesToFinancialStatementsAbstract xbrli:stringItemType  Duration    Yes
     
custom:PromissoryNotePayableInterestRate num:percentItemType  Instant    Yes
  custom:PromissoryNotePayableInterestRate  
custom:RelatedPartyTransactionsDetailsNarrativeAbstract xbrli:stringItemType  Duration    Yes
     
custom:SajoConsultingAgreementDate xbrli:dateItemType  Duration    Yes
     
custom:ShareholderPaymentOnBehalfOfCompany xbrli:monetaryItemType  Duration    Yes
     
custom:StockholdersEquityDetailsNarrativeAbstract xbrli:stringItemType  Duration    Yes
     
custom:SummaryOfSignificantAccountingPoliciesPoliciesAbstract xbrli:stringItemType  Duration    Yes
     
custom:SupplementalCashFlowInformationDetailsAbstract xbrli:stringItemType  Duration    Yes
     
custom:SupplementalCashFlowInformationTablesAbstract xbrli:stringItemType  Duration    Yes
     
dei:AmendmentFlag xbrli:booleanItemType  Duration     
  If the value is true, then the document is an amendment to previously-filed/accepted document.  
dei:CurrentFiscalYearEndDate xbrli:gMonthDayItemType  Duration     
  End date of current fiscal year in the format --MM-DD.  
dei:DocumentFiscalPeriodFocus dei:fiscalPeriodItemType  Duration     
  This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.  
dei:DocumentFiscalYearFocus xbrli:gYearItemType  Duration     
  This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.  
dei:DocumentPeriodEndDate xbrli:dateItemType  Duration     
  The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.  
dei:DocumentType dei:submissionTypeItemType  Duration     
  The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".  
dei:EntityCentralIndexKey dei:centralIndexKeyItemType  Duration     
  A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.  
dei:EntityCommonStockSharesOutstanding xbrli:sharesItemType  Instant     
  Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.  
dei:EntityCurrentReportingStatus dei:yesNoItemType  Duration     
  Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.  
dei:EntityFilerCategory dei:filerCategoryItemType  Duration     
  Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.  
dei:EntityIncorporationDateOfIncorporation xbrli:dateItemType  Duration     
  Date when an entity was incorporated  
dei:EntityIncorporationStateCountryName xbrli:normalizedStringItemType  Duration     
  State or Country Name where an entity is incorporated  
dei:EntityPublicFloat xbrli:monetaryItemType  Instant  Credit   
  State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.  
dei:EntityRegistrantName xbrli:normalizedStringItemType  Duration     
  The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.  
dei:EntityVoluntaryFilers dei:yesNoItemType  Duration     
  Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  
dei:EntityWellKnownSeasonedIssuer dei:yesNoItemType  Duration     
  Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.  
us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.  
us-gaap:AccountsPayableCurrent xbrli:monetaryItemType  Instant  Credit   
  Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).  
us-gaap:AccruedLiabilitiesCurrent xbrli:monetaryItemType  Instant  Credit   
  Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).  
us-gaap:AdditionalPaidInCapital xbrli:monetaryItemType  Instant  Credit   
  Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.  
us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract xbrli:stringItemType  Duration     
   
us-gaap:Assets xbrli:monetaryItemType  Instant  Debit   
  Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.  
us-gaap:AssetsAbstract xbrli:stringItemType  Duration     
   
us-gaap:AssetsCurrent xbrli:monetaryItemType  Instant  Debit   
  Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.  
us-gaap:AssetsCurrentAbstract xbrli:stringItemType  Duration     
   
us-gaap:BankingAndThriftAbstract xbrli:stringItemType  Duration     
   
us-gaap:BasisOfAccountingPolicyPolicyTextBlock nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  
us-gaap:Cash xbrli:monetaryItemType  Instant  Debit   
  Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.  
us-gaap:CashAndCashEquivalentsPolicyTextBlock nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.  
us-gaap:CashFlowSupplementalDisclosuresTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.  
us-gaap:CashPeriodIncreaseDecrease xbrli:monetaryItemType  Duration  Debit   
  Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.  
us-gaap:CommonStockParOrStatedValuePerShare num:perShareItemType  Instant     
  Face amount or stated value per share of common stock.  
us-gaap:CommonStockSharesAuthorized xbrli:sharesItemType  Instant     
  The maximum number of common shares permitted to be issued by an entity's charter and bylaws.  
us-gaap:CommonStockSharesIssued xbrli:sharesItemType  Instant     
  Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.  
us-gaap:CommonStockSharesOutstanding xbrli:sharesItemType  Instant     
  Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.  
us-gaap:CommonStockValue xbrli:monetaryItemType  Instant  Credit   
  Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.  
us-gaap:DueToRelatedPartiesCurrent xbrli:monetaryItemType  Instant  Credit   
  Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).  
us-gaap:EarningsPerShareBasicAndDiluted num:perShareItemType  Duration     
  The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.  
us-gaap:EarningsPerSharePolicyTextBlock nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.  
us-gaap:FairValueOfFinancialInstrumentsPolicy nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for determining the fair value of financial instruments.  
us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.  
us-gaap:IncomeStatementAbstract xbrli:stringItemType  Duration     
   
us-gaap:IncomeTaxPolicyTextBlock nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.  
us-gaap:IncomeTaxesPaid xbrli:monetaryItemType  Duration  Credit   
  The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.  
us-gaap:IncreaseDecreaseInAccountsPayable xbrli:monetaryItemType  Duration  Debit   
  The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties xbrli:monetaryItemType  Duration  Debit   
  The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.  
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet xbrli:monetaryItemType  Duration  Credit   
  The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.  
us-gaap:IncreaseDecreaseInOperatingCapitalAbstract xbrli:stringItemType  Duration     
   
us-gaap:InterestExpense xbrli:monetaryItemType  Duration  Debit   
  Amount of the cost of borrowed funds accounted for as interest expense.  
us-gaap:InterestExpenseOther xbrli:monetaryItemType  Duration  Debit   
  Amount of interest expense classified as other.  
us-gaap:InterestPaid xbrli:monetaryItemType  Duration  Credit   
  Amount of cash paid for interest. Includes, but is not limited to, payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.  
us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims xbrli:monetaryItemType  Duration  Debit   
  Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.  
us-gaap:Liabilities xbrli:monetaryItemType  Instant  Credit   
  Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.  
us-gaap:LiabilitiesAndStockholdersEquity xbrli:monetaryItemType  Instant  Credit   
  Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.  
us-gaap:LiabilitiesCurrent xbrli:monetaryItemType  Instant  Credit   
  Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.  
us-gaap:LiabilitiesCurrentAbstract xbrli:stringItemType  Duration     
   
us-gaap:LicenseCosts xbrli:monetaryItemType  Duration  Debit   
  Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark.  
us-gaap:NatureOfOperations nonnum:textBlockItemType  Duration     
  The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.  
us-gaap:NetCashProvidedByUsedInFinancingActivities xbrli:monetaryItemType  Duration  Debit   
  Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.  
us-gaap:NetCashProvidedByUsedInFinancingActivitiesAbstract xbrli:stringItemType  Duration     
   
us-gaap:NetCashProvidedByUsedInOperatingActivities xbrli:monetaryItemType  Duration     
  Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.  
us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract xbrli:stringItemType  Duration     
   
us-gaap:NetIncomeLoss xbrli:monetaryItemType  Duration  Credit   
  The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.  
us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.  
us-gaap:NotesPayable xbrli:monetaryItemType  Instant  Credit   
  Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.  
us-gaap:NotesPayableCurrent xbrli:monetaryItemType  Instant  Credit   
  Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.  
us-gaap:OperatingCostsAndExpenses xbrli:monetaryItemType  Duration  Debit   
  Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.  
us-gaap:OperatingCostsAndExpensesAbstract xbrli:stringItemType  Duration     
   
us-gaap:OtherExpenses xbrli:monetaryItemType  Duration  Debit   
  Amount of expense classified as other.  
us-gaap:OtherExpensesAbstract xbrli:stringItemType  Duration     
   
us-gaap:OtherGeneralAndAdministrativeExpense xbrli:monetaryItemType  Duration  Debit   
  Amount of general and administrative expense classified as other.  
us-gaap:PreferredStockParOrStatedValuePerShare num:perShareItemType  Instant     
  Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.  
us-gaap:PreferredStockSharesAuthorized xbrli:sharesItemType  Instant     
  The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.  
us-gaap:PreferredStockSharesIssued xbrli:sharesItemType  Instant     
  Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.  
us-gaap:PreferredStockSharesOutstanding xbrli:sharesItemType  Instant     
  Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.  
us-gaap:PreferredStockValue xbrli:monetaryItemType  Instant  Credit   
  Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.  
us-gaap:ProceedsFromNotesPayable xbrli:monetaryItemType  Duration  Debit   
  The cash inflow from a borrowing supported by a written promise to pay an obligation.  
us-gaap:RelatedPartyTransactionsDisclosureTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.  
us-gaap:RepaymentOfNotesReceivableFromRelatedParties xbrli:monetaryItemType  Duration  Debit   
  The cash inflow from a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.  
us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.  
us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.  
us-gaap:RetainedEarningsAccumulatedDeficit xbrli:monetaryItemType  Instant  Credit   
  The cumulative amount of the reporting entity's undistributed earnings or deficit.  
us-gaap:RevenueRecognitionPolicyTextBlock nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.  
us-gaap:Revenues xbrli:monetaryItemType  Duration  Credit   
  Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).  
us-gaap:RevenuesAbstract xbrli:stringItemType  Duration     
   
us-gaap:SalesRevenueNet xbrli:monetaryItemType  Duration  Credit   
  Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.  
us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock nonnum:textBlockItemType  Duration     
  Tabular disclosure of supplemental cash flow information for the periods presented.  
us-gaap:ScheduleOfRepurchaseAgreements nonnum:textBlockItemType  Duration     
  The entire disclosure for repurchase agreements.  
us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.  
us-gaap:SignificantAccountingPoliciesTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure for all significant accounting policies of the reporting entity.  
us-gaap:StatementLineItems xbrli:stringItemType  Duration     
  Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.  
us-gaap:StatementOfCashFlowsAbstract xbrli:stringItemType  Duration     
   
us-gaap:StatementOfFinancialPositionAbstract xbrli:stringItemType  Duration     
   
us-gaap:StatementTable xbrli:stringItemType  Duration     
  Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.  
us-gaap:StockIssuedDuringPeriodSharesIssuedForServices xbrli:sharesItemType  Duration     
  Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.  
us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited xbrli:sharesItemType  Duration     
  Number of shares (or other type of equity) forfeited during the period.  
us-gaap:StockIssuedDuringPeriodValueIssuedForServices xbrli:monetaryItemType  Duration  Credit   
  Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.  
us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited xbrli:monetaryItemType  Duration  Debit   
  Value of forfeitures of stock or other type of equity issued of any equity-based compensation plan other than an employee stock ownership plan (ESOP).  
us-gaap:StockholdersEquity xbrli:monetaryItemType  Instant  Credit   
  Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.  
us-gaap:StockholdersEquityAbstract xbrli:stringItemType  Duration     
   
us-gaap:StockholdersEquityNoteDisclosureTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.  
us-gaap:SubsequentEventsTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.  
us-gaap:SubstantialDoubtAboutGoingConcernTextBlock nonnum:textBlockItemType  Duration     
  The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.  
us-gaap:SupplementalCashFlowInformationAbstract xbrli:stringItemType  Duration     
   
us-gaap:TitleOfIndividualAxis xbrli:stringItemType  Duration     
  Information by title of individual or nature of relationship to individual or group of individuals.  
us-gaap:TitleOfIndividualWithRelationshipToEntityDomain nonnum:domainItemType  Duration     
  Title of individual, or nature of relationship to individual or group of individuals.  
us-gaap:UseOfEstimates nonnum:textBlockItemType  Duration     
  Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.  
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted xbrli:sharesItemType  Duration     
  Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).  
Total Elements   126
Total Non-Abstract Elements   95
Total Extension Elements   18
Percent Extended   14%
Percent Extended (excluding abstracts)   7%
Total Facts   178
(End Elements)